2. Screening Libraries
  3. FDA-Approved Drug Library Mini

FDA-Approved Drug Library Mini

Cat. No.: HY-L022M
Library Contents: XLSX PDF SDF

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication. First, the risk of failure is lower. Second, the time frame for drug development can be reduced. Third, less investment is needed. Approved drugs have identified bioactivities, good pharmacokinetic characteristics and safety which are suitable for drug repurposing.

MCE owns a unique collection of 2905 approved compounds which have been completed extensive preclinical and clinical studies and have well-characterized bioactivities, safety and bioavailability properties. The package of this library is 96-well microplate with peelable foil seal, which makes the screening process easier and faster.

FDA-Approved Drug Library Mini
Size (Pre-dissolved Solution) Price Stock
10 μL/well Solution

10 mM , 2 mM and 3 mg/mL
Pre-dissolved Solution

 Get quote In-stock
Download Screening Library Catalog

Please contact us at

[email protected]

Top Publications Citing Use of Products

Publications Citing Use of MCE Compound Libraries

  • Description

  • Product Details

  • Documentation

Description
& Advantages
  FDA-Approved Drug Library Mini FDA-Approved Drug Library (Cat. No.: HY-L022)
Size 10 μL in DMSO 30, 50, 100, and 200 μL in DMSO
Package 96-well microplate with peelable foil seal 96-Well Format Sample Storage Tube With Screw Cap
Delivery Date Within three days About one month
Price Per Set Low High
Preparation For Use Tear off the seal film on the microplate If there is no robot, each tube needs to be manually opened

FAQ
Product Details
Formulation:
A collection of 2905 marketed drugs supplied as pre-dissolved Solutions
Solution: 2829 compounds supplied in 10 mM solution, 55 compounds supplied in 2 mM solution, 21 compounds supplied in 3 mg/mL solution.
Layout:
96-well storage tube or 96-well plate: 1st and 12th column are left empty.
384-well plate: the first two columns and the last two columns are left empty.
Compounds with different concentrations or dissolved in different solvents will be put on separate plates. This way of layout may increase the number of plates because there could be three solvents and three concentrations.
If you have other requirements, please let us know.
Container:
96-well Plate With Peelable Foil Seal
Storage:
In solvent: -80°C 2 years, -20°C 1 year; Powder: -20°C 3 years, 4°C 2 years
Shipping:
Blue ice
Documentation

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Inquiry Online

Inquiry Information

Product Name:
FDA-Approved Drug Library Mini
Cat. No.:
HY-L022M
Quantity:
MCE Japan Authorized Agent:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.

  • 96-well Plate with Peelable Foil Seal
  • 384-well Microplate with Peelable Foil Seal
  • 96-well Storage Tubes with Rack
  • 96-well Storage Tubes with Rack
  • 96-well Plate with Peelable Foil Seal
  • 384-well Microplate with Peelable Foil Seal
  • 96-well Storage Tubes with Rack
  • 96-well Storage Tubes with Rack

Request for SDF File

Please fill out this form to request the SDF file. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Applicant Name *

Email Address *

 

Organization Name *

Phone Number

     

Remarks

Request for SDF File

We have received your request and will respond to you as soon as possible.